Erie Retina Research — Erie, Pennsylvania

Public research footprint of Erie Retina Research, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Geographic Atrophy · Diabetic Macular Edema · Neovascular Age-related Macular Degeneration · Wet Age Related Macular Degeneration

Recently updated registry entries

NCT06574997 — Expanded Access Program for RP in Adults (No Longer Available)
NCT05956626 — A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease (Active Not Recruiting)
NCT06388200 — A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Erie Retina Research?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.